According to GuruFocus Insider Data, the largest insider sells during the past week were: CVS Health Corp, Monster Beverage Corp, ConAgra Foods Inc, and Envision Healthcare Holdings Inc.
The overall trend of insiders is illustrated in the chart below:
CVS Health Corp (CVS, Financial): EVP Per G.H. Lofberg sold 347,343 Shares
EVP Per G.H. Lofberg sold 347,343 shares of CVS stock on 01/02/2015 at the average price of $95.28. Per G.H. Lofberg owns at least 223,119 shares after this. The price of the stock has increased by 2.77% since.
CVS Health Corp has a market cap of $112.25 billion; its shares were traded at around $97.92 with a P/E ratio of 25.50 and P/S ratio of 0.86. The dividend yield of CVS Health Corp stocks is 1.12%. The company had an annual average earnings growth of 12.60% over the past 10 years. GuruFocus rated CVS Health Corp the business predictability rank of 4.5-star.
CVS has released its third quarter 2014 results. Net revenues increased 9.7% to $35.0 billion, operating profit increased 4.3% to $2.2 billion, and adjusted EPS increased 9% to $1.15. Same store sales increased 2% over the prior year quarter.
President and CEO Larry J Merlo sold 144,144 shares of CVS stock on 01/05/2015 at the average price of $94.3. EVP & President, CVS/Caremark Jonathan C Roberts sold 86,487 shares of CVS stock on 01/07/2015 at the average price of $95.31. Multiple other insiders also recently sold shares of CVS stock.
Monster Beverage Corp (MNST, Financial): Vice Chairman and President Hilton H Schlosberg sold 300,000 Shares
Vice Chairman and President of Monster Beverage Corp (MNST, Financial) Hilton H Schlosberg sold 300,000 shares during the past week at an average price of $117.04.
Monster Beverage Corp has a market cap of $19.62 billion; its shares were traded at around $117.04 with a P/E ratio of 47.10 and P/S ratio of 8.48. Monster Beverage Corp had an annual average earnings growth of 32.70% over the past 10 years. GuruFocus rated it the business predictability rank of 3-star.
Monster Beverage Corp reported third quarter net sales of $636.0 million, a 7.7% increase from the prior year quarter. Net income increased 31.9% to $121.6 million.
Chairman and CEO Rodney C Sacks sold 100,000 shares of MNST stock on 01/06/2015 at the average price of $111.69.
ConAgra Foods Inc (CAG, Financial): Paul T Maass sold 392,000 Shares
Pres-Private Paul T Maass sold 392,000 shares of CAG stock on 01/05/2015 at the average price of $35.85. Paul T Maass owns at least 63,060 shares after this. The price of the stock has increased by 1.09% since.
ConAgra Foods Inc has a market cap of $15.44 billion; its shares were traded at around $36.24 with a P/E ratio of 39.10 and P/S ratio of 0.88. The dividend yield of ConAgra Foods Inc stocks is 2.76%. The company had an annual average earnings growth of 4.90% over the past 10 years. GuruFocus rated ConAgra Foods Inc the business predictability rank of 3-star.
The company has released its fiscal second quarter 2015 results ended November 23, 2014. Diluted EPS from continuing operations were $0.05 due to significant impairment charges. Adjusted for this, EPS were $0.61 compared with $0.62 a year ago. Consumer Foods sales were down 2% for the quarter.
EVP and CFO John Gehring sold 160,000 shares of CAG stock on 12/22/2014 at the average price of $36.82. EVP, Chief HR Officer Nicole B Theophilus, SVP, Treasurer&Asst. Secretary Scott E Messel, and multiple other insiders all also sold shares of CAG stock.
Envision Healthcare Holdings Inc (EVHC, Financial): EVP, COO and CFO Randel G Owen sold 200,000 Shares
EVP, COO and CFO Randel G Owen sold 200,000 shares of EVHC stock on 01/08/2015 at the average price of $36.56. Randel G Owen owns at least 577,683 shares after this. The price of the stock has increased by 0.46% since.
Envision Healthcare Holdings Inc has a market cap of $6.74 billion; its shares were traded at around $36.73 with a P/E ratio of 83.70 and P/S ratio of 1.69.
Envision reported third quarter adjusted EPS of $0.35 and net revenue of $1.15 billion, an increase of 20.3% over the prior year quarter. Adjusted EBITDA increased 25.1% to $152.2 million.
For the complete list of stocks that bought/sold by their company executives, go to: Insider Buys.
